Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis; Disease Relapse or a new Entity?

Lung cancer is still diagnosed in advanced stage and most patients do not have the opportunity for surgical treatment. Although in the recent years new diagnostic equipment is available such as the radial and linear endobronchial ultrasound (EBUS) and electromagnetic fiberoptic bronchoscopy. However; novel targeted therapies with tyrosine kinase inhibitors of second generation and immunotherapy are available. In this commentary we will focus on eye metastasis after initiation of tyrosine kinase inhibitors due to epidermal growth factor mutation of lung cancer adenocarcinoma.